Drug Shortage Report for LYDERM
Report ID | 173614 |
Drug Identification Number | 00716863 |
Brand name | LYDERM CREAM 0.05% |
Common or Proper name | Lyderm |
Company Name | TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC. |
Market Status | MARKETED |
Active Ingredient(s) | FLUOCINONIDE |
Strength(s) | 0.05% |
Dosage form(s) | CREAM |
Route of administration | TOPICAL TOPICAL |
Packaging size | 60 |
ATC code | D07AC |
ATC description | CORTICOSTEROIDS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-07-19 |
Estimated end date | 2023-05-05 |
Actual end date | 2023-05-05 |
Shortage status | Resolved |
Updated date | 2023-05-08 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2022-11-03 | French | Compare |
v1 | 2022-11-03 | English | Compare |